2024 DMRF Funding Announcement: Abigail Wilson, PhD, University College London

In her study, An In Vivo Drug Repurposing Screen to Identify Novel Treatments for DYT-TOR1A Dystonia, Dr. Wilson aims to find new drug treatments for patients with DYT-TOR1A dystonia. In this video, she explains how using fly models with the same genetic mutation, she will test medications used for other disorders to see if they positively impact the dystonia symptoms. She hopes this will facilitate further therapeutic options for dystonia patients.
For more information about dystonia research and support for living with dystonia, visit the Dystonia Medical Research Foundation at dystonia-found...